Overview
Rapid and efficient organism identification and antimicrobial susceptibility reports are paramount for patient survival during sepsis. The Bruker MBT Sepsityper® Kit US IVD allows harvesting of microorganisms directly from positive blood cultures and pairs it with the Bruker MALDI Biotyper® CA System for rapid identification of bacterial isolates using MALDI-TOF technology. Here we compare the accuracy of the MBT Sepsityper® Kit US IVD for bacterial identification to culture-based methods. Further, as an off-label use of the kit, we compare the antimicrobial susceptibility results for Gram-negative bacteria setup directly using the harvested pellet to the established method in the laboratory.
![Performance comparison of Bruker MBT Sepsityper® Kit US IVD for culture-independent identification and antimicrobial susceptibility testing from positive blood cultures](https://static.wixstatic.com/media/97db43_1bca205a12b440dabeb7f6c39cdc13d2~mv2.png/v1/fill/w_49,h_17,al_c,q_85,usm_0.66_1.00_0.01,blur_2,enc_auto/digital%20Marketing%20(1450%20%C3%97%20788%20px).png)
Performance comparison of Bruker MBT Sepsityper® Kit US IVD for culture-independent identification and antimicrobial susceptibility testing from positive blood cultures
1 November 2022 at 4:00:00 pm
![Lindsey Singer, MS](https://static.wixstatic.com/media/97db43_fe80deed29a846d3829fda7083c75f33~mv2.jpg/v1/fill/w_120,h_120,al_c,q_80,blur_3,enc_auto/Lindsey%20Singer.jpg)
Lindsey Singer, MS
Clinical Laboratory Technologist